Yumin Choi
Partner @ Bain Capital Ventures
Boston, United States
Yumin Choi is a Series B investor at Bain Capital Ventures in Boston focused on Health Care and Medical. Yumin Choi is the Managing Partner at Valspring Capital. Additionally, Yumin Choi has had 5 past jobs including a Partner at Bain Capital Ventures. Yumin received a BS from Babson College.
- Total investments:
- 25
- Last investment:
- Lead investor:
- 56%
Last updated:
For AI agents: llms.txt
Industries Yumin Choi invests in
Stages Yumin Choi invests in
Countries Yumin Choi invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 15 (60%)
- Medical 7 (28%)
- Therapeutics 3 (12%)
- Information Technology 3 (12%)
- Pet 2 (8%)
Stage
- Series B 8 (32%)
- Funding Round 4 (16%)
- Series A 3 (12%)
- Series D 3 (12%)
- Series C 2 (8%)
Country
- United States 17 (68%)
- Canada 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Pediatrica provides pediatric primary care and health services for children and adolescents. The organization offers wellness visits, prevention screening, early detection, chronic disease management, behavioral health, and newborn care. It supports families through telemedicine options and after-hours access for urgent concerns. Pediatrica alsoprovides same-day appointments and care coordination through a patient portal. In addition, the organization participates in research and education to improve health outcomes for children and young adults. | $28M / Series B / Jul 07, 2026 | ||
| Cardamom Health is a healthcare IT data, analytics, and applications company that provides solutions to healthcare organizations. The company is dedicated to enhancing lives by assisting healthcare organizations in optimizing their data and EHR applications. With an emphasis on both people and technology, we strive to foster an environment thatempowers our diverse team to flourish and achieve outstanding results. | Private Equity / Jan 12, 2026 | ||
| Parallel Learning provides a digital platform that delivers psycho-educational services and special-education support to students with learning and thinking differences. The company specializes in virtual neurodevelopmental assessments and support services for conditions such as dyslexia, dysgraphia, dyscalculia, and executive dysfunction. Parallelenables students to get to the root of the problem and provides them the resources and encouragement to succeed in the classroom by helping them build confidence, strength, and strategies to work around weaknesses.It offers a range of services, including psychological and neurodevelopmental evaluations, speech-language therapy, behavioral and mental-health counseling, specialized instruction in reading, writing, and math, and executive-function coaching. Through a nationwide network of licensed psychologists, special-education teachers, and therapists, Parallel Learning matches each student with appropriate providers and tailors support plans based on individual needs. | $20M / Series B / Dec 09, 2025 | ||
| Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused. The company provides superior care, unrivaled transparency, and tech-enabled convenience to help pets and pet parents live better lives together. Founded in 2017, Small Door is headquartered in New York. | Jul 29, 2025 | ||
| Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused. The company provides superior care, unrivaled transparency, and tech-enabled convenience to help pets and pet parents live better lives together. Founded in 2017, Small Door is headquartered in New York. | $35M / Series C / Jul 29, 2025 | ||
| Koala has all the medications and health products your pet needs. We package them by date and time to make pet care simpler. The best part? There are no service or shipping fees — you only pay for what your pet needs. | $20M / Series B / May 07, 2025 | ||
| Phoenix Digital Health is a digital healthcare platform that offers telehealth solutions for men, providing access to virtual consultations, health assessments, treatment plans, and ongoing support for various health concerns, including sexual health, mental health, and chronic conditions, while ensuring that users can connect with licensedhealthcare professionals through secure messaging and video calls, facilitating convenient and discreet healthcare management tailored to individual needs. | $34.7M / Series A / Mar 13, 2025 | ||
| Legacy provides a service for at-home sperm testing and cryopreservation, allowing individuals to take control of their fertility health from the comfort of their homes. Their semen analysis is conducted in CLIA-certified labs, ensuring high-quality testing without the need for direct doctor involvement. As America's largest at-home fertilityclinic for men, Legacy empowers clients to understand their reproductive health and plan for the future effectively. | $25M / Series B / May 12, 2023 | ||
| Topography Health is creating new opportunities in clinical research. | $21.5M / Series A / Jan 19, 2022 | ||
| Centivo is a new type of health plan administrator that allows self-funded employers and clinicians to join forces and deliver high quality, affordable healthcare to their employees. An alternative to traditional insurance carriers or third-party administrators, Centivo offers the technology, network, claims processing, customer support, andpopulation health management to fully administer health benefits for all or a portion of an employee population. The Centivo model emphasizes the partnership between individuals and their primary care team as the proper model to coordinate healthcare needs. Centivo’s clinical partners are dedicated to controlling costs and helping members navigate the healthcare system, aided by personalized patient/doctor matching tools. Members are rewarded for working with their primary care team and choosing high-value care and are supported through a user-friendly app and their concierge. Employers get an ally that diligently roots out waste and is accountable for performance.It was formed in 2017 and headquartered in New York, United States. | $51M / Series B / Sep 22, 2021 | ||
| See all 25 investments → | |||
Co-Investors
About Bain Capital Ventures
With over $10B under management, Bain Capital Ventures (BCV) offers distinctive access to Bain Capital's broader industry expertise and portfolio of companies. For over 20 years, BCV has invested from seed through IPO and acquisition, backing more than 400 companies including Attentive, Bloomreach, Clari, Docusign, Flywire, LinkedIn,Moveworks, Redis, Rubrik and ShipBob.
Bain Capital Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Benjamin Nye
Senior Advisor
|
|||
Kevin Zhang
Partner
|
|||
Michael Krupka
Partner
|
|||
Paul Zurlo
Partner & COO
|
|||
Ron Miasnik
Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yumin Choi invest in?
Yumin Choi invests primarily in Health Care, Medical and Therapeutics startups, most often at Series B and Funding Round stage. Most of the 25 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Yumin Choi?
Public channels for Yumin Choi include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Yumin Choi last invest?
The most recent investment recorded for Yumin Choi closed in Jul 2026. Shizune tracks 25 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
